Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALTH
DataHoraFonteTítuloCódigoCompanhia
31/08/201213:50ZacksSPPI a Step Closer to Allos - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/08/201207:57Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCHNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/08/201207:03Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/08/201207:02Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
28/08/201219:46Business WireSpectrum Pharmaceuticals & Allos Therapeutics Announce That FTC Clears Transaction; Tender Offer for Shares of Allos Common S...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
22/08/201213:05Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/08/201207:00ZacksSpectrum Extends Allos Buyout Offer - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/08/201218:32Business WireSpectrum Pharmaceuticals & Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therap...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/08/201217:18Edgar (US Regulatory)Amended Quarterly Report (10-Q/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/08/201210:01Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/07/201217:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/07/201210:25Dow Jones NewsUS HOT STOCK FUTURES: HOT STOCKS TO WATCHNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/06/201217:16Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/06/201206:30ZacksSpectrum Extends Allos Tender Offer - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
22/05/201217:51Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/05/201208:00Business WireSpectrum Pharmaceuticals & Allos Therapeutics Announce Extension of Previously Announced Tender Offer For Shares of Allos The...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/05/201206:45ZacksAllos Narrows Loss, Awaits Takeover - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/05/201219:57Business WireRobbins Geller Rudman & Dowd LLP Files Class Action Suit Against Allos Therapeutics, Inc.NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/04/201217:18Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/04/201214:45ZacksBad News for Allos - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/04/201210:54Business WireAllos Therapeutics Announces Outcome of Request for Re-examination of CHMP Opinion for FOLOTYN® in EuropeNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/04/201217:59Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/04/201209:15Business WireSpectrum Pharmaceuticals Commences Tender Offer for All Outstanding Shares of Allos TherapeuticsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/04/201207:04Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/04/201207:04Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/04/201218:11Edgar (US Regulatory)Amended Annual Statement of Changes in Beneficial Ownership (5/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/04/201212:26Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/04/201209:15ZacksAllos Eyed by Spectrum Pharma - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/04/201206:06ZacksCompany News for April 9, 2012 - Corporate SummaryNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/04/201207:07Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALTH